Beike Biotechnology

Beike Biotechnology (full name: Shenzhen Beike Biotechnology Co., Ltd.), a Chinese biotechnology company, was founded in July 2005 by Xiang Hu, with funding from Peking University, the Hong Kong University of Science and Technology, and Shenzhen City Hall. The company specializes in research, clinical translation, and technology support services for adult stem cells, and does not work with human embryonic stem cells (hESC). Beike Biotechnology’s mission, according to its website, is “to be the world leader in stem cell research and clinical translation, to make comprehensive cellular therapy accessible and cost-effective, and to improve each patient’s quality of life.”

Beike Biotechnology has 450 employees, with subsidiaries located in China and India: Jiangsu Beike, Anhul Beike, Guizhou Beike, Henan Beike, Liaoning Beike, Beike (Hong Kong) International, and ...